Surveillance based lyme disease network (SUBLYME)

Ended Definitive Contract Awarded Last action

Contract number
75D30124C18824
Awardee
Awarding agency
Obligated
$1,103,281

Award facts

Opportunity
  • 75D30124Q77657 Solicitation number
Contract value 100% obligated
$1,103,280.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Fort Collins, CO 80521, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 · EO 14398 $0
Exercise an Option P00002 $610,098
Other Administrative Action P00001 $0
Original award $493,183

About this award

The Centers for Disease Control and Prevention awarded a $1.1 million definitive contract to Geisinger Clinic for the Surveillance Based Lyme Disease Network (SUBLYME) on September 30, 2024, under firm fixed price terms with no set-aside.

Place of performance is Fort Collins, Colorado. The contract's ultimate completion date is September 29, 2026. The work supports CDC surveillance and epidemiological research related to Lyme disease, leveraging Geisinger's electronic health record systems and clinical research capabilities to develop and maintain a national disease surveillance network.

Quick answers

Who was awarded contract 75D30124C18824?

75D30124C18824 was awarded to Geisinger Clinic by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 30, 2024.

How much is contract 75D30124C18824 worth?

The government has obligated $1,103,281 on 75D30124C18824.

Was contract 75D30124C18824 competed?

The extent of competition for 75D30124C18824 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award